‘Ozempic for smoking' pill that ‘significantly improves quit rate' to be rolled out on the NHS – are you eligible?
A PILL dubbed the 'Ozempic for smoking' is available again in the UK and back on the NHS after years away from pharmacy shelves.
Drug firm Pfizer announced its drug varenicline, known as Champix, is back in supply.
It was pulled in 2021 due to a potentially hazardous problem with the ingredients, which has now been fixed.
Experts have welcomed its return as it is regarded as the best way to quit.
Professor Nick Hopkinson, lung disease expert at Imperial College London, said: 'Varenicline is the most effective smoking cessation medication, so the fact that it has not been available for the last few years has been a real problem.'
Works like a fat jab
The daily pill works by attaching to the same receptors in the brain that would be targeted by nicotine.
This means it reduces cravings as if someone has just had a cigarette, and also blocks the receptor so nicotine does not work, preventing the 'reward' feeling if they do smoke.
That works the same way as weight loss injections which block hormone receptors to prevent hunger.
The drug will be available through NHS Stop Smoking clinics or through a GP surgery, and will be offered alongside counselling and other quitting support.
Patients may be asked to try other ways of stopping smoking before they are offered medication.
Around eight million people in the UK smoke tobacco and it is the leading cause of cancer.
Dr Andy McEwen, chief of the National Centre for Smoking Cessation and Training, said: 'The availability of this medication offers people a stop smoking aid that may significantly improve their chances of quitting.'
The NHS now plans to roll it out through official stop smoking services.
People can refer themselves for help online via the NHS website.
The clinics also began using a second pill, named cytisine, last year.
Both have been proven to be more effective than nicotine patches or gum, and equally as good as vaping.
Health chiefs announced in November that clinics would use the pill again and experts at University College London estimated it could save 9,500 lives by 2030.
Former NHS chief Amanda Pritchard said at the time: 'This simple daily pill could be a game-changer.'
Professor Hopkinson, also medical director of the charity Asthma + Lung UK, added: ' Quitting smoking is the best thing you can do for your health.'
The truth about smoking
ONE in eight people in the UK smokes.
And yet it's the biggest cause of death and disease that we can control.
About half of life-long smokers will die early, losing about 10 years of life on average.
The most common smoking -related causes of death are: lung cancer, chronic obstructive pulmonary disease, and coronary heart disease.
But it is linked to all sorts of other conditions, from heart attacks and strokes to diabetes and depression.
Smoking harms every organ in the body, which is why it accounts for approximately 74,600 deaths every year in England alone.
It kills more people annually than having a high BMI, alcohol and drugs combined.
Around 506,100 NHS hospital admissions in people over the age of 35 are attributable to smoking, accounting for four per cent of all hospital admissions in this age group.
Smoking also costs the NHS in England about £1.9billion a year.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
41 minutes ago
- BBC News
What's Up Docs? Doctors' Notes: Hair Loss
Hair we go again! Chris and Xand are back with a bonus episode, as they continue their conversation with Dr Christos Tziotzios, Consultant Dermatologist and Senior Lecturer at Kings College London. They learn about a particular type of hair loss which predominantly affects women, investigate the hair growth cycle, and discuss the psychological impact of losing your hair. Plus, what connects the Black Death hundreds of years ago with modern-day hair loss? If you'd like to share your thoughts on this or any other topic covered on the podcast, you email us at whatsupdocs@ or Whatsapp on 08000 665 123. Presenters: Drs Chris and Xand van Tulleken Guest: Dr Christos Tziotzios Producer: Jo Rowntree Executive Producer: Rami Tzabar Editor: Kirsten Lass Assistant Producer: Maia Miller-Lewis Assistant Producer and Researcher: William Hornbrook Tech Lead: Reuben Huxtable Social Media: Leon Gower Digital Lead: Richard Berry Composer: Phoebe McFarlane Sound Design: Melvin Rickarby At the BBC: Assistant Commissioner: Greg Smith Commissioning Editor: Rhian Roberts A Loftus Media production for BBC Radio 4.
The Independent
an hour ago
- The Independent
Five-year-old boy died from allergic reaction after eating biscuit at school
A five-year-old boy, described as "kind-souled," tragically died from a severe allergic reaction after collapsing at his primary school, an inquest has been told. Benedict Blythe, who was in his first year at Barnack Primary School in Stamford, Lincolnshire, died in hospital on 1 December 2021, following an incident at school where he vomited. His mother, Helen Blythe, delivered heartbreaking testimony on the first day of the inquest at Peterborough Town Hall. "Benedict was not just a child with allergies, he was a whole universe – curious, funny, kind and loving – and the world should have been safer for him," she stated. Benedict, who had known allergies to milk, eggs, and some nuts, had his cause of death recorded as food-induced anaphylaxis, according to Elizabeth Gray, the area coroner for Cambridgeshire and Peterborough. Ms Gray told the jury: 'Benedict was five years old at the time of his death. 'He suffered from asthma and a number of allergies including milk and an egg allergy.' The inquest heard Benedict was kept home from school on November 30 because he was unwell and had vomited the previous night, but went to school as normal on December 1. The coroner said Benedict ate a biscuit during that school day which he had brought from home and then was offered oat milk by a class teacher, but he refused to drink it. He then vomited so his parents were called to pick him up, but he vomited a second time and was taken outside for fresh air where he 'collapsed'. An adrenaline auto-injector (AAI) was administered by a first aid-trained teaching assistant but Benedict was 'not responding' before CPR was attempted. Emergency services were called but the schoolboy died later that day at Peterborough City Hospital. Benedict's mother, who gave evidence to the inquest, told the jury that vomiting was 'always' the first symptom of his allergic reactions, but 'how it played out after that varied'. She said the school was given a management plan with 'things we knew as a family and as his parents' about his allergic reactions. In a witness statement read to the inquest, Mrs Blythe said Benedict was 'well-aware' of his allergic reactions, adding: 'I believe he had an allergic reaction and this is what caused his death.' She added that Benedict 'woke up as normal and in good health' that morning with no temperature or cough. She described feeling 'terrified' when she learnt that Benedict had become unwell. The inquest heard that Benedict was 'not necessarily adventurous' with food but had become 'increasingly anxious' about asking whether things contained milk because of previous allergic reactions. Dr Emilia Wawrzkowicz, a consultant paediatrician, said the initial post-mortem examination report recorded Benedict's cause of death as asthma but she felt 'very strongly' that it was due to anaphylaxis. She told the court: 'The original post-mortem report had concluded on the balance of probabilities that the cause of death was asthma. I whole-heartedly disagreed with this. I was shocked to have seen this.' She said one of the reasons she believed this was because there was 'never any suggestion of airway compromise'. A video was shown to the jury of Benedict opening his advent calendar before school with his younger sister on the day he died. Mrs Blythe told the inquest the chocolate he ate from the advent calendar was dairy-free. She also read a pen portrait to the inquest, saying: 'Quick-minded and kind-souled, Benedict's love of 'playing numbers' was one hint to why he joined Mensa when he was four. 'His superpower was his kind heart, and it's that kindness that is so missing from our lives. 'The first return to a new school year after his death, children said 'I wish Benedict was here – he'd stop me feeling nervous'. 'Aside from the joy Benedict had in his life, he had to develop his own quiet kind of bravery. 'He lived with allergies and chronic asthma, and sometimes that meant missing out — on parties, on snacks other children could eat, on ice creams from the ice cream van – but he never let it define him. 'The day Benedict died, our world broke but what's even more unbearable is the knowledge that we weren't alone. 'Benedict was not just a child with allergies, he was a whole universe – curious, funny, kind and loving – and the world should have been safer for him.' The Benedict Blythe Foundation was set up in his memory and, along with The Allergy Team and the Independent Schools' Bursars Association (ISBA), launched the schools allergy code last year to protect children with allergies and set out how schools can keep pupils safe. The inquest, which is expected to last two weeks, continues.
Daily Mail
an hour ago
- Daily Mail
Expert issues major warning to users of period tracker apps
Experts have issued an urgent warning to people using period tracker apps over fears that their data is being sold to third party companies. The mobile phone apps, designed to help people track their periods by counting the days they are menstruating, have proved hugely popular in recent years, with the biggest three - Flo, Clue and Period Tracker - downloaded by more than 250 million. A recent study by University of Cambridge 's Minderoo Centre warned users to exercise caution when using the applications - calling them a 'gold mine' for consumer profiling. Users who allow tracking on the app may be exposing their private information to major tech companies, who can use it to deliver targeted ads based on their menstrual cycle, the study suggested. Researchers warned that the intimate nature of the information could have far greater consequences in real life, with access to abortion, health insurance and even job prospects at risk. Leaked information could also make them vulnerable to discrimination and cyberstalking. Dr Stefanie Felsberger, the lead author of the report, said: 'There are real and frightening privacy and safety risks to women as a result of the commodification of the data collected by cycle tracking app companies.' The report called on official health bodies, including the NHS, to take action to create 'safer' alternatives to the apps currently on the market. According to the report, while data from period-tracking apps is held under special protections against being sold externally, consent options aren't always implemented, meaning advertisers - such as Google and Facebook - can easily get their hands on private information. Companies can use information from period tracking apps to target women according to their cycle, offering up beauty and pregnancy adverts during ovulation. Researchers told the BBC that data relating to who wants to be pregnant was some of the most 'sought-after information in digital advertising' as it's the 'most likely' driver of changes in shopping habits. This information can be up to 200 times more valuable than data on gender, age and location. Dr Felsberger said: 'Menstrual cycle tracking apps are presented as empowering women and addressing the gender health gap. 'Yet the business model behind their services rests on commercial use, selling user data and insights to third parties for profit. 'There are real and frightening privacy and safety risks to women as a result of the commodification of the data collected by cycle tracking app companies.' In addition to concerns regarding data leaks, information on women's health could also impact their reproductive care. According to an investigation by Tortoise Media, there have been instances whereby police have been able to request such data from period tracker apps when investigating women who have illegally accessed abortion services. Earlier this year, the National Police Chiefs' Council released guidance that permitted officers to investigate cases where a pregnancy loss, such as a miscarriage, stillbirth or early labour, could be the result of an illegal abortion. Responding to the findings, Rhiannon White, CEO of period tracking app Clue told The Mirror she was 'disappointed' by the news, adding that apps like theirs offered women 'agency' where public health system have 'failed' them in the past. She added that 97 per cent of users used the app to help monitor a myriad of health and reproductive issues, highlighting that it was wrong simply to view apps though a 'narrow fertility lens'. Some of those include hormone conditions such as PCOS, or endometriosis. Worldwide, one in 5 women are affected PCOS, a hormone disorder characterised by erratic or absent periods and cysts in the ovaries. And one in 10 people are thought to have endometriosis, a chronic disease associated with severe, life-impacting symptoms such as pain and heavy bleeding. It's caused by tissue similar to the lining of the uterus grows outside the uterus. Adenomyosis is another reproductive condition - thought to imapct one in five people, it's symptoms also include severe pain in the abdomen and throughout the body, as well as heavy periods. Sue Khan, VP of Security and Data Protection Officer at Flo told the publication she supported efforts to ensure that it's users felt safe when using the app and that the highest standards of data protection were being implemented. In 2022, the company introduced 'Anonymous Mode', a feature that gave people access to Flo without having to include their name, email address, or any technical identifiers.
